Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Gavan

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Transplantation|October 1, 1981
Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine culturesM Duston, M C McHenry, W F Braun, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Delaware Medical Journal|November 1, 1971
Cephapirin: clinical, pharmacological, and microbiological studiesS Jameson, M C McHenry, R A VanOmmen, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinR N Jones, P C Fuchs, H M Sommers, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Microbiology|February 1, 1986
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Transplantation|October 1, 1981
Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine culturesM Duston, M C McHenry, W F Braun, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Delaware Medical Journal|November 1, 1971
Cephapirin: clinical, pharmacological, and microbiological studiesS Jameson, M C McHenry, R A VanOmmen, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycinR N Jones, P C Fuchs, H M Sommers, et al.
Pageof 10